# DrugStoc

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drugstoc

- Industry: Internet
- Headquarters: Lagos, Nigeria
- Website: www.drugstoc.com
- Total disclosed funding: $4.4M
- Latest round: Series A (Nov 15, 2021)
- Investors on record: 3

## About

DrugStoc is a procurement platform focused on anti-counterfeit medications and medical supplies, catering primarily to healthcare providers in emerging markets. It enhances access to authentic healthcare products through a centralized and efficient system.DrugStoc is an innovative procurement platform that specializes in providing authentic medications and medical supplies. Founded in 2012 and headquartered in Lagos, Nigeria, the company has completed 3 deals to date. In November 2021, it raised USD 4.4 mn in Series A funding led by AAIC Holdings, with investment participation from DEG and VestedWorld. The CEO, Chibuzo Opara, oversees operations, continuing the vision established by founder Adham Yehia.DrugStoc offers a procurement platform designed to provide anti-counterfeit medications and essential medical supplies, collaborating with over 400 pharmaceutical manufacturers. Its extensive catalog features more than 7,000 items, including specialty medications, medical consumables, and rare drugs. The platform streamlines procurement for healthcare providers, including pharmacies, hospitals, clinics, and health maintenance organizations, primarily in Africa and emerging economies, ensuring reliable access to quality healthcare products.The revenue model for DrugStoc revolves around a business-to-business (B2B) strategy, facilitating transactions between healthcare providers and pharmaceutical manufacturers. Clients order products directly through the platform, which also offers additional services such as inventory automation and access to collateral-free loans. Pricing structures include transaction fees and possible subscription models, positioning DrugStoc as a key player in the healthcare supply chain.Following the recent Series A funding of USD 4.4 mn raised in November 2021, DrugStoc plans to utilize these resources to enhance its platform capabilities and expand its market presence. The company is focused on launching new products designed to improve the procurement experience for healthcare providers. Additionally, DrugStoc aims to enter new markets across Africa and other emerging regions by 2023, enhancing access to healthcare products and services.

## Funding rounds

- Series A, Nov 15, 2021, $4.4M — DEG, VestedWorld, AAIC Holdings

## Investors

- DEG — Series A
- VestedWorld (https://capitalatlas.ai/funds/vestedworld) — Series A
- AAIC Holdings — Series A